OLMA Showing Recent Insider Activity
is showing several healthtech companies
with insider buying activity. Click to view all recent health sector insider activity here
According to a new post on politicsandwallstreet.com, Olema Pharmaceuticals, OLMA
is showing recent insider trading activity. Public SEC records indicate that Cyrus Harmon
recently Sold $116,200
worth of shares on 1 week ago.
Based on this transaction and a few others from Corporate Insiders of OLMA
that Bought 1,720,312 worth of shares in the last 3 months, the Insider Confidence level of Olema Pharmaceuticals
is trending Up.
Since these insiders have unique insights into what's happening at Olema Pharmaceuticals, this might serve as an indicator of where it is headed. finmarketnews.com follow all insider transactions from a number of sources and many of these are added to our watchlists.For the full story including other insider activity for OLMA click here >>
One resource you need to consider using Tipranks.com
where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
This information was sourced from politicsandwallstreet.com, as well as various 3rd party public sources but to get the best insight into insider activity related to OLMA,
you should consider joining TipRanks.com.
FinMarketNews.com keeps investors informed of the top moving stocks within each sector including Health & Biotech, Technology, Energy, Metals & Mining, Financial, Consumer, Communication Services and more. We provide investors with timely information regarding top moving stocks that is sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to FinMarketNews.com.
Disclaimer: Sandpiper Marketing Group, LLC would like to remind you the data contained in this website is not necessarily real-time nor accurate. All stocks, indexes, futures and Forex prices are not provided by exchanges but rather by our editor research at the time of writing this release, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Sandpiper Marketing does not bear any responsibility for any trading losses you might incur as a result of using this data. Sandpiper Marketing Group, LLC or anyone involved with Sandpiper Marketing Group, LLC will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in this website/newsletter is not trustworthy unless verified by their own research. Also, because events/circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.